• 1
    Madamanchi, N. R., Vendrov, A., Runge, MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 25: 2938.
  • 2
    Evans, J. L., Goldfine, I. D., Maddux, B. A., Grodsky, GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction. Diabetes 52: 18.
  • 3
    Keaney, J. F., Larson, M. G., Vasan, R. S., et al (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 23: 434439.
  • 4
    Urakawa, H., Katsuki, A., Sumida, Y., et al (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 88: 46734676.
  • 5
    Furukawa, S., Fujita, T., Shimabukuro, M., et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 114: 17521761.
  • 6
    Morrow, JD (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol. 25: 279286.
  • 7
    Takanishi, K., Nammour, T. M., Fukunaga, M., et al (1992) Glomerular actions of a free-radical-generated novel prostaglandin, 8-epi-prostaglandin F in the rat: evidence for interaction with thromboxane A2 receptors. J Clin Invest. 90: 136141.
  • 8
    Minuz, P., Andrioli, G., Degan, M., et al (1998) The F2-isoprostane 8-epi-prostaglandin F increases platelet adhesion and reduces antiadhesive and antiaggregatory effects of NO. Arteriolscler Thromb Vasc Biol. 18: 12481256.
  • 9
    Scholz, H., Aukrust, P., Tonstad, S., et al (2004) 8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells. Eur J Clin Invest. 34: 451458.
  • 10
    Schwehelm, E., Bartling, A., Lenzen, H., et al (2004) Urinary 8-isoprostaglandin F as a risk marker of in patients with coronary artery disease: a matched case-control study. Circulation 109: 843848.
  • 11
    Soares, A. F., Guichardant, M., Cozzone, D., et al (2005) Effects of oxidative stress on adiponectin secretion and lactate production in 3T3–L1 adipocytes. Free Radic Biol Med. 38: 882889.
  • 12
    Nakanishi, S., Yamane, K., Kamei, N., Nojima, H., Okubo, M., Kohno, NA (2004) Protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54: 194199.
  • 13
    Yamauchi, T., Kamon, J., Waki, H., et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7: 941946.
  • 14
    Hu, E., Liang, P., Spiegelman, BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 271: 1069710703.
  • 15
    Mohan, V., Deepa, R., Pradeepa, R., et al (2005) Association of low adiponectin levels with the metabolic syndrome: the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 54: 476481.
  • 16
    Ciabattoni, G., Davi, G., Collura, M., et al (2000) In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med. 162: 11951201.
  • 17
    Davi, G., Ciabattoni, G., Consoli, A., et al (1999) In vivo formation of 8-iso-prostaglandin F and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224229.
  • 18
    Davi, G., Alessandrini, P., Mezzetti, A., et al (1997) In vivo formation of 8-iso-prostaglandin F is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 17: 32303235.
  • 19
    Manning, P. J., Sutherland, W. H. F., Walker, R. J., et al (2004) Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care 27: 21662171.
  • 20
    Wexler, D. J., Hu, F. B., Manson, J. E., Rifai, N., Meigs, JB (2005) Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obesity Res. 13: 17721783.
  • 21
    Upritchard, J. E., Schuurman, CRWC, Wiersma, A., et al (2003) Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults. Am J Clin Nutr. 78: 985992.
  • 22
    Tatzber, F., Griebenow, S., Wonisch, W., Winkler, R. (2003) Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase in peroxidase activity in human sera. Anal Biochem. 316: 147153.
  • 23
    Sloan, J. C., Lappin, TRJ (1982) Automated colorimetric determination of alpha-tocopherol. Clin Chim Acta. 119: 197207.
  • 24
    Meagher, E. A., Barry, O. P., Lawson, J. A., Rokach, J., Fitzgerald, GA (2001) Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285: 11781182.
  • 25
    Patrignani, P., Panara, M. R., Tacconelli, S., et al (2000) Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 102: 539545.
  • 26
    Rielly, M., Delanty, N., Lawson, J. A., Fitzgerald, GA (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 1925.
  • 27
    Weinberg, R. B., Werken, Vander B. S., Anderson, R. A., Stegner, J. E., Thomas, MJ (2001) Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Thromb Vasc Biol. 21: 10291033.
  • 28
    Upston, J. M., Terentis, A. C., Stocker, R. (1999) Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 13: 977994.
  • 29
    Daví, G., Guagnano, M. T., Ciabattoni, G., et al (2002) Platelet activation in obese women-role of inflammation and oxidant stress. JAMA 288: 20082014.
  • 30
    Venugopal, S., Devaraj, S., Yang, T., Jialal, I. (2002) α-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-α. Diabetes 51: 30493054.
  • 31
    Calvisi, D. F., Ladu, S., Hironaka, K., Factor, V. M., Thorgeirsson, SS (2004) Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-α transgenic mouse model of liver cancer. J Hepatol. 41: 815822.
  • 32
    Cnop, M., Havel, P. J., Utzschneider, K. M., et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459469.
  • 33
    Nishizawa, H., Shimomura, I., Kishida, K., et al (2002) Androgens decrease plasma adiponectin, and insulin-sensitizing adipocyte-derived protein. Diabetes 51: 27342741.
  • 34
    Xu, A., Chan, K. W., Hoo, R. L. C., et al (2005) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 280: 1807318080.
  • 35
    No authors listed (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial: Gruppo Italiano per lo Studio della Sopravvivenza nell’ Infarto Miocardico. Lancet 354: 447455.
  • 36
    Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., Sleight, P. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342: 154160.
  • 37
    Gross, M., Steffes, M., Jacobs, D. R., Jr, et al (2005) Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem. 51: 125131.
  • 38
    Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R., Appel, L. J., Guallar, E. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 142: 3746.
  • 39
    Hathcock, J. N., Azzi, A., Blumberg, J., et al (2005) Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 81: 736745.
  • 40
    Block, G., Dietrich, M., Norkus, E. P., et al (2002) Factors associated with oxidative stress in human populations. Am J Epidemiol. 156: 274285.